Hyposalivation
18
0
0
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
2 terminated out of 18 trials
83.3%
-3.2% vs benchmark
11%
2 trials in Phase 3/4
10%
1 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (18)
Evaluation of an Oral Care Kit for Maintaining the Oral Health of Patients Admitted to the Intensive Care Unit
Photobiomodulation in Oral Lesions Resulting From Anti-neoplastic Prevention
Effectiveness of Photobiomodulation Protocols in Radiation-induced Oral Side Effects in H&N Cancer Patients
Effectiveness of Extraoral Photobiomodulation in Management of Oral Adverse Effects in Patients Undergoing HSCT
Fluoride Retention in the Mouth of Older Adults
Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth
Mesenchymal Stem Cells for Radiation-induced Xerostomia
Eletric Stimulation for Hipossalivation Induced by Radiotherapy
The Effect of Biotene® on the Symptoms of Xerostomia and Mastication and Swallowing
Effects of Aqualief® in Patients With Xerostomia as Consequence of Radiotherapy for Head and Neck Cancer
The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors
Quality of Life and Sjögren Syndrome
Hyposalivation Response To Transcutaneous Electrical Nerve Stimulation In Diabetic Type 2 Patients
Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome
Low Level Laser Therapy for Hyposalivation
The Effect of Probiotic Streptococci and pH-rising Components on the Oral Microbial Flora
A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study
Effect of Saliva Substitutes on Dental Hard Tissues in Situ